SINTX net loss widens 17% to $2.71 million in Q2 FY26; revenue more than doubled to $452,000
SINT•Business update
The company said it recorded initial sales of its SiNAPTIC Foot & Ankle Osteotomy Wedge.
SINTX also said there is still substantial doubt about its ability to continue as a going concern.
Quarterly results
SINTX Technologies posted a net loss of $2.71 million in the second quarter, widening 17% from a year earlier.
Revenue rose to $452,000, more than doubling from the prior-year period, driven by an increase in product revenue to $447,000.
Margins and expenses
Operating loss widened to $2.89 million, while gross profit increased to $278,000.
Selling and marketing expense rose to $273,000, reflecting product launch costs and higher expenses tied to additional hiring.
